Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Sumen Cenk — MAXCYTE, INC. insider: 2 transactions · InsiderLens

Home / Insiders / Sumen Cenk

Sumen Cenk

Chief Scientific Officer at MAXCYTE, INC. · on record since Mar 17, 2022

Insider trading activity of Sumen Cenk

Transactions on record: 2; since Mar 21, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 21, 2023

Figures computed from official regulatory filings — methodology.

Companies where Sumen Cenk has traded

MAXCYTE, INC.2 tx · Mar 21, 2023

Track record of Sumen Cenk

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Sumen Cenk

Co-insiders of Sumen Cenk

Ahuja ParmeetMAXCYTE, INC.
Al-Wakeel Yasir B.MAXCYTE, INC.
BALTHROP PATRICK JMAXCYTE, INC.
Brooke William WMAXCYTE, INC.
Casdin Capital, LLCMAXCYTE, INC.
Casdin EliMAXCYTE, INC.
Casdin Partners GP, LLCMAXCYTE, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Casdin Partners Master Fund, L.P.MAXCYTE, INC.

Collins CynthiaMAXCYTE, INC.

Doerfler DouglasMAXCYTE, INC.

DOUGLAS RICHARDMAXCYTE, INC.

Erck Stanley CMAXCYTE, INC.

Hemrajani RekhaMAXCYTE, INC.

Holtz RonMAXCYTE, INC.

Johnston John JosephMAXCYTE, INC.

Mandell ArtMAXCYTE, INC.

Masoud MaherMAXCYTE, INC.

Murphy Amanda LouiseMAXCYTE, INC.

Ross Thomas M.MAXCYTE, INC.

Sandoval David I.MAXCYTE, INC.

Soleymannezhad AliMAXCYTE, INC.

Swirsky Douglas JMAXCYTE, INC.

THOMPSON J STARK PHDMAXCYTE, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
MAXCYTE, INC.	Mar 21, 2023	AwardD	120,000	0.00 USD	$0	SEC
MAXCYTE, INC.	Mar 21, 2023	AwardD	500,000	0.00 USD	$0	SEC